RecruitingCoronary Artery DiseaseCoronary Artery Disease Risk HighComplex Coronary Artery Disease
IVUS CHIP UPP Registry
Eligible age
18+ yrs
Accepts
All genders
Locations
11 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The IVUS CHIP UPP Registry is a prospective, observational, multicenter, single-arm registry. A total of 1010 patients with complex coronary lesions will be enrolled in up to 2 years, with at least 500 men and women. All patients will be treated with IVUS-guided PCI.
Sponsor: ECRI bv
You may qualify if…
- ✓ 1. The patient must be ≥18 years of age and self-identify within a US census-defined minority
- ✓ 2. Patients with an indication for PCI of at least one lesion satisfying any of the following criteria:
- ✓ 1. Angiographic heavy calcification
- ✓ 2. Ostial lesions
- ✓ 3. True bifurcation lesions involving side-branches \>2.5mm
- ✓ 4. Left main lesions
- ✓ 5. Chronic total occlusion
- ✓ 6. In-stent restenosis
You may not qualify if…
- ✕ 1. ST-elevation myocardial infarction or cardiogenic shock within prior 7 days
- ✕ 2. Known untreated severe valvular heart disease
- ✕ 3. Contraindication on the use of IVUS (i.e. extreme vessel tortuosity)
- ✕ 4. Requiring PCI in a diseased aorto-coronary bypass
- ✕ 5. Known contraindication or hypersensitivity to anticoagulants
- ✕ 6. Absolute contraindications or allergy that cannot be pre-medicated, to iodinated contrast or to antiplatelet drugs, including both aspirin and P2Y12 inhibitors
- ✕ 7. Non-cardiac co-morbidities with a life expectancy less than 1 year
- ✕ 8. A patients that is currently participating in a clinical trial that has not yet reached its primary endpoint cannot be included in this registry. A patient may only be enrolled in this registry once.
Where it's recruiting
Arizona
Phoenix
California
Loma Linda
Florida
Coral Gables · Orlando · Tampa · Weston
Georgia
Atlanta
Illinois
Chicago
Kentucky
Louisville
Michigan
Detroit
Minnesota
Duluth
Mississippi
Jackson
New Jersey
Jersey City · Marlton
Rhode Island
Providence
Source: ClinicalTrials.gov · NCT06625801 · last updated 2026-09-23